Azusa Sugiyama - Concepedia

Author

Azusa Sugiyama

Tokyo University of Science

Also Known As

A Sugiyama, A. Sugiyama, Azusa Sugiyama, Tomio Hashimoto

Publications

574

Citations

H-Index

Concepts

All Affiliations

Tokyo University of Science National Institute of Mental Health National Center of Neurology and Psychiatry Kitasato University University of Tsukuba

About

Azusa Sugiyama is an author at Tokyo University of Science specializing in pharmacology, medicine, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	284
2	Social Sciences	5	5	175
3	Neuroscience	5	5	175
4	Cognitive Science	1	1	18
5	Endocrinology	1	1	33

Azusa Sugiyama

Publications

515

Citations

H-Index

Page 1

	Year	Citations
Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan Akira Iwanami, Azusa Sugiyama, Noriomi Kuroki, Acta Psychiatrica Scandinavica	1994	134
The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions Akiyoshi Saitoh, Azusa Sugiyama, Toru Nemoto, Behavioural Brain Research Molecular PharmacologyPain DisordersPsychiatryPain MedicineMedicine	2011	96
Activation of the prelimbic medial prefrontal cortex induces anxiety‐like behaviors via N‐Methyl‐D‐aspartate receptor‐mediated glutamatergic neurotransmission in mice Akiyoshi Saitoh, Masanori Ohashi, Satoshi Suzuki, Journal of Neuroscience Research	2014	60
The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines Akiyoshi Saitoh, Azusa Sugiyama, Misa Yamada, Neuropharmacology Molecular PharmacologyPsychoactive DrugDistinct Anxiolytic-like EffectsPsychiatryAddiction	2012	44
Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines Azusa Sugiyama, Akiyoshi Saitoh, Takashi Iwai, Neuropharmacology Psychoactive DrugDistinct Anxiolytic-like EffectsPharmacological StudyMedicinePsychotropic Medication	2012	38
Glucagon-like peptide-2 but not imipramine exhibits antidepressant-like effects in ACTH-treated mice Takashi Iwai, Tomoko Ohnuki, Sachie Sasaki‐Hamada, Behavioural Brain Research NeuropeptidesPsychiatryGlucagon-like Peptide-2MedicinePhysiology	2013	33
The impairment in spatial learning and hippocampal LTD induced through the PKA pathway in juvenile-onset diabetes rats are rescued by modulating NMDA receptor function Hiroaki Sacai, Sachie Sasaki‐Hamada, Azusa Sugiyama, Neuroscience Research NeuropsychologySpatial LearningBrain FunctionNeurophysiologyPka Pathway	2014	25
Glucagon-like peptide-2-induced memory improvement and anxiolytic effects in mice Takashi Iwai, Kazushi Jin, Tomoko Ohnuki, Neuropeptides MedicineMemory LossMemoryNeuropharmacologyAnxiolytic Effects	2014	23
DOR2-selective but not DOR1-selective antagonist abolishes anxiolytic-like effects of the δ opioid receptor agonist KNT-127 Azusa Sugiyama, Hiroshi Nagase, Jun‐Ichiro Oka, Neuropharmacology Molecular PharmacologyBehavioural PharmacologyBehavioral PharmacologyPharmacologyNeuropharmacology	2013	19
Systemic administration of riluzole enhances recognition memory and facilitates extinction of fear memory in rats Azusa Sugiyama, Akiyoshi Saitoh, Masatoshi Inagaki, Neuropharmacology Cognitive ScienceCognitive NeuroscienceBehavioral NeuroscienceMedicineNeurobiological Factor	2015	18

Page 1